2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate

C80H150N4O6S2 — CID 174190953

IUPAC2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate
SMILESCC/C=C\C/C=C\C/C=C\CCCCCC[C@H](O)CN(C[C@@H](O)CCCCCC/C=C\C/C=C\C/C=C\CC)C(C)CCSSCCN1CCN(CCOC(=O)CCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CC1
InChIInChI=1S/C80H150N4O6S2/c1-6-10-14-18-22-26-30-32-34-36-40-44-48-52-57-78(87)73-84(74-79(88)58-53-49-45-41-37-35-33-31-27-23-19-15-11-7-2)75(5)60-69-91-92-70-67-82-64-62-81(63-65-82)66-68-90-80(89)59-54-61-83(71-76(85)55-50-46-42-38-28-24-20-16-12-8-3)72-77(86)56-51-47-43-39-29-25-21-17-13-9-4/h10-11,14-15,22-23,26-27,32-35,75-79,85-88H,6-9,12-13,16-21,24-25,28-31,36-74H2,1-5H3/b14-10-,15-11-,26-22-,27-23-,34-32-,35-33-/t75?,76?,77?,78-,79-/m0/s1
InChIKeyLYBOZBCQMARGOS-GMCYXOSVSA-N
MW1328.24 g/mol
LogP20.16
Rot. Bonds69

About 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate

2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate (PubChem CID 174190953) has the molecular formula C80H150N4O6S2 and a molecular weight of 1328.24 g/mol. Its IUPAC name is 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate.

Molecular Properties

Compound Name2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate
PubChem CID174190953
Molecular FormulaC80H150N4O6S2
Molecular Weight1328.24 g/mol
Exact Mass1327.10
IUPAC Name2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate
SMILESCC/C=C\C/C=C\C/C=C\CCCCCC[C@H](O)CN(C[C@@H](O)CCCCCC/C=C\C/C=C\C/C=C\CC)C(C)CCSSCCN1CCN(CCOC(=O)CCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CC1
InChIInChI=1S/C80H150N4O6S2/c1-6-10-14-18-22-26-30-32-34-36-40-44-48-52-57-78(87)73-84(74-79(88)58-53-49-45-41-37-35-33-31-27-23-19-15-11-7-2)75(5)60-69-91-92-70-67-82-64-62-81(63-65-82)66-68-90-80(89)59-54-61-83(71-76(85)55-50-46-42-38-28-24-20-16-12-8-3)72-77(86)56-51-47-43-39-29-25-21-17-13-9-4/h10-11,14-15,22-23,26-27,32-35,75-79,85-88H,6-9,12-13,16-21,24-25,28-31,36-74H2,1-5H3/b14-10-,15-11-,26-22-,27-23-,34-32-,35-33-/t75?,76?,77?,78-,79-/m0/s1
InChIKeyLYBOZBCQMARGOS-GMCYXOSVSA-N
XLogP20.16
TPSA120.18 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds69
Heavy Atoms92
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001328.24
LogP ≤ 520.16
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'disulphide', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate?
The IUPAC name of 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate (CID 174190953) is 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate.
What is the SMILES notation for 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate?
The canonical SMILES for 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate is CC/C=C\C/C=C\C/C=C\CCCCCC[C@H](O)CN(C[C@@H](O)CCCCCC/C=C\C/C=C\C/C=C\CC)C(C)CCSSCCN1CCN(CCOC(=O)CCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CC1.
What is the InChIKey of 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate?
The InChIKey is LYBOZBCQMARGOS-GMCYXOSVSA-N. The full InChI is InChI=1S/C80H150N4O6S2/c1-6-10-14-18-22-26-30-32-34-36-40-44-48-52-57-78(87)73-84(74-79(88)58-53-49-45-41-37-35-33-31-27-23-19-15-11-7-2)75(5)60-69-91-92-70-67-82-64-62-81(63-65-82)66-68-90-80(89)59-54-61-83(71-76(85)55-50-46-42-38-28-24-20-16-12-8-3)72-77(86)56-51-47-43-39-29-25-21-17-13-9-4/h10-11,14-15,22-23,26-27,32-35,75-79,85-88H,6-9,12-13,16-21,24-25,28-31,36-74H2,1-5H3/b14-10-,15-11-,26-22-,27-23-,34-32-,35-33-/t75?,76?,77?,78-,79-/m0/s1.
What are the key properties of 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate?
2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate has a molecular weight of 1328.24 g/mol, XLogP of 20.16, 69 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[2-[3-[bis[(2S,9Z,12Z,15Z)-2-hydroxyoctadeca-9,12,15-trienyl]amino]butyldisulfanyl]ethyl]piperazin-1-yl]ethyl 4-[bis(2-hydroxytetradecyl)amino]butanoate is sourced from PubChem (CID 174190953), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).